1. This study was performed on a large set of 13C-urea breath test results to determine the optimal cut-off point of the test for the diagnosis of Helicobacter pylori (Hp) infection.
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.00 6%0, with a risk of false-negative or -positive response of the urea breath test of less than 3%.
From this, a cut-off point of +3.006%0 for the 13C-urea breath test is recommended, with an indetermined zone between +2.5 and +3.56%0 to account for the spontaneous variation of 13C02 in breath and the limits of GC-isotope ratio-MS analytical precision.
Administration has cleared and approved a UBT application (Mereteck U B P ) for the diagnosis of Hp infection. UBT has been recognized as the best non-invasive test to control the efficacy of anti-Hp treatments [2-41. ThiS indirect diagnostic test relies on the urease activity of Hp: when present in the gastric cavity, Hp meFabolizes 13C-urea given orally to ammoniac and I3CO2, which is then readily detectable in breath. The UBT is performed, after an overnight fast, by' obtaining two breath samples (through a plastic straw placed at the bottom of a 10ml glass tube closed immediately at the end of a 20s exhalation), one before (To) and the second 30min (T30) after oral administration of 75 mg of I3C-labelled urea, to measure 13C enrichment in COa. A citric acid solution (200 ml) is also given orally before the administration of labelled urea, to slow down gastric emptying and ensure a sufficient contact time between urea and the gastric mucosa [5] . I3C enrichment (T3O-TO) is then calculated, yielding a negative or positive result for Hp infection. There is still some controversy about the best cut-off point; early reports used (T30-To) = 5 6%0 13C enrichment [5, 61. However, using receiver operative characteristic curve analysis of UBT results compared with histological analysis of gastric biopsy specimens in 95 patients, we found the cut-off point (T30-To) = 3 6%0 to improve the sensitivity of the test without decreasing its specificity [7] . The goal of the present study was to confirm this cut-off point by statistical analysis of a larger set of data.
INTRODUCTION
The 13C-urea breath test (UBT) is now a widely used test to document Helicobacterpylori (Hp) infection [l] . Recently, the American Food and Drug an anti-Hp treatment (post-treatment group), were used for this study. All these patients were included in therapeutic protocols approved by the French National Ethics Committee to evaluate the efficacy of triple therapy regimens (two antibiotics and a proton-pump inhibitor for 7-14 days), and the UBTs were performed as requested in these protocols. To control F-ip eradication, UBTs were always done at least 4 weeks after the end of treatment. Similarly, the results of UBTs performed for the diagnosis of Hp infection in 173 children younger than 17 years old were used. For children, the same protocol as in adults was used, except for the dose of '3C-labelled urea: 50 mg was given orally instead of 75 mg. Furthermore, in children under the age of 4, a mask was used for breath sampling.
In each case, I3CO2 enrichment in To and T~o breath samples was measured by GC-isotope ratio-
MS (IRMS) at a central facility, and (T.w-T(,)
values were calculated and expressed in 6960 [S] . In the three groups of patients, visual analysis of the histograms of (T~o--To) values showed a mix of two positively skewed populations: the logarithmic transformation of (Tw-TO), ln(T3o-To), transformed these distributions into symmetrical (normal) ones (Fig. 1 ). Thcse two populations wcre presumed to be representative of Hp-negative and Hp-positive patients.
The normal distribution of ln(T3o -TO) allowed cluster analysis to be performed on these data, in order to determine the minimal intra-class variance [9] , and thus the In(7'3o -To) value best separating the presumed Hp-negative and Hp-positive populations. Thereafter, the parameters (mean and SD) of these Hp-negative and Hp-positive populations wcre established. These parameters were then used in the equation of normal distribution to draw the frequency curves for both Hp-negative and Hp-positive populations. The intersection between the two curves corresponds to the ln(7'3o-To) value at which the probability tilts over: below this value, it is more likely for an individual to belong to the Mp-negative group; above this value, it is most likely for an individual to be Hp positive. The optimal (T30-zl) cutoff point is then obtained from the In(T3o-To) intersection value.
Finally, in the thrce groups of UBT results, the ln(Tw--TO) cut-off value was standardized for each presumed Hp-negative and Hp-positive distribution, according to the formula Z = (Xi -p ) /~ (where Xi = cut-off point, p = mean of the population and a = S D ) . The 2 value (called the normal deviate) indicates how many SDs from the mean the cutoff point is locatcd. The Z values obtained wcre thcn reported lo the table of the proportions of the normal curve, which gives the proportion of the normal curve that is more extreme than a given normal deviate Z [lo]. Thus, the probability for a given individual Mp negative to produce a URT result correpsonding to an In( Tm -TO) value greater than the cut-off point (ix. a false-positive result), as well as the probability for a patient belonging to the Hp-positivc population producing a UBT result corresponding to an ln(T30 -To) value smaller than the cut-off point (is. a false-negative result), was determined. (Fig. 2) , obtain the intersection point of these two curves, and thus the (T30-To) cut-off point. The intersection point was found to be ln(T30-TO) = 1.18 in the adult diagnosis group, 1.01 in the adult posttreatment group, and 1.00 in the paediatric group. Thus, the optimal UBT cut-off point was (T30-TO) = (called normal deviate) between the cut-off point (Xi) and the mean ( p ) of each normal distribution, expressed in SDs ( a ) . The normal deviates were found to be greater than two SDs (>2a) in all cases, indicating, by reporting these values to the table of the proportions of the normal curvc, that the proportions of HP-negative and Hp-positive populations respectively producing a UBT result greater or smaller than the cut-off point were always lower than 2.3%. Thus, the risks of false positivity or false negativity of the UBT for the diagnosis of Hp infection are lower than 2.3% when using a (T3O-To)
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cut-off point of (a) 3.25 6%0 in the adult population before any anti-Hp treatment; (b) 2.756%0 in the adult population after treatment; and (c) 2.72 6960 in the paediatric population.
Replacing the cut-off points obtained for the three different groups of patients by the same UBT (T30-To) cut-off point of 3.006%0, as determined in our previous study [7] , the corresponding normal deviates, 2, for both Hp-negative and -positive distributions were greater in all cases than 1.94 SDs (1.940). Thus, according to the table of the proportions of the normal curve, the risks or error of the UBT with this cut-off point were still lower than 3%, a more than adequate efficacy for a non-invasive test.
DISCUSSION
Using a statistical cluster analysis of a large set of UBT data, we were able to confirm the validity of the cut-off point of (T3O-TO) = 3.00 6%0 for the diagnosis of Hp infection, determined by receiver operative characteristic curve analysis compared with histological analysis of gastric biopsy specimens used as the gold standard in a previous study [7] . The theoretical interest of the statistical method used here is to allow the analysis of a large set of data without the need of a gold standard to be used as reference. Interestingly, the UBT cut-off point as determined by statistical cluster analysis was very similar to that previously obtained by comparison with a gold standard.
With regard to the slight variations in the precision of the UBT when modifying its cut-off point around 3 6%0, it does not appear to be useful to use different cut-off points depending on the clinical situation (before or after treatment) or the population tested (adults or children): a cut-off point of (T3O-To) = 3.00 6%0 seems applicable in all cases.
In fact, rather than set a very strict cut-off point for the UBT, it would make more sense to determine a 'grey zone' for this test, in which the risk of error of the test is maximal. For individuals having a UBT result falling in this 'grey zone', a second test or a different diagnostic method (such as a direct test on gastric biopsy specimens) would be recommended to assess more accurately their Hp status. Such a 'grey zone' would also take into account the spontaneous fasting individual variation of respiratory I3CO2 (around f0.76%0, [ll]), as well as the analytical precision of the GC-IRMS 13C02 measurements (1 SD = 0.2 6%0, [S] ). If a 'grey zone' set for (T3O-To) values between 2.5 and 3.5 6%0 was applied to the population tested, 2.3% of the patients tested in the adult diagnosis group (16 of 696 patients), only 0.7% of the adults tested after treatment (seven of 1056 patients) and 1.7% of the children tested (three of 173) would have fallen in it. The UBT would thus be inconclusive with regard to Hp infection in approximately 1.4% of the patients. Finally, it must be stressed that the 3.006%0 cut-off point may not be valid if the UBT is performed according to a different protocol. For example, some studies have shown that the UBT may be less accurate if performed in the non-fasting state [12] or with a test meal other than citric acid [13] . In these cases, the optimal cut-off point of the test may be different.
In conclusion, this study shows that it is possible to estimate the cut-off point of UBT by cluster analysis of a large set of data, without comparison with a gold standard. It confirms the validity of the (T3Ov-o) = 3.00 6%0 cut-off point for the diagnosis of Hp infection. The study also underlines the necessity of a 'grey zone' in which the accuracy of the UBT does not allow a precise determination of the Hp status for a given individual.
